FDA Investigator Tammy S Notto
Tammy S Notto has inspections in 1 countries as of 18 Jul 2023. Tammy S Notto has collaborated with a combined 1280 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
41
Last Inspection Date:
18 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amy W Yan Mai,
Andrew F Cohen,
Ann B Okon,
Arthur G Hurst,
Bruce G Cooper,
Carl A Huffman, III,
Carolyn J Cook,
Dana A Razzano,
Daniel L Aisen,
Demitria J Xiradakis,
Diamond M Oden,
Dipesh K Shah,
Donald G Gordon,
Dr. Robert C Horan, MD,
Elizabeth H Davis,
Erin L Nagel,
Geoffrey B Ward,
Harry J Brewer,
Hilary K Wagner,
James D Bridges,
Jeanette L Mcginnis,
Joanne M Schlossin,
Joel R Merriman,
Joseph A Famiglietti,
Joseph J Vannelli,
Joseph T Frost,
Joshua D Lopez,
Joyce A Williams,
Judy Keihl,
Julie Scoma,
Karen L Kosar,
Karen R Smallwood,
Kathryn A Nagy,
Kenneth G Klobus,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kyle J Spencer,
Lauren E Blaser,
Lawrence H Patrick,
LCDR Chad N Thompson,
Linda M Sacco,
Lisa Mathew,
Manhar R Patel,
Marc S Neubauer,
Marcia D Fields,
Margaret E Sarles,
Marlene L Davis,
Mary F Finn,
Mary M Finn,
Mary T Carden,
Matthew D Schnittker,
Michael A Charles,
Michael W Burd,
Mindy M Chou,
Nicholas C Mendiola,
Patricia A Clark,
Paul E Stein,
Peter M Trunk,
Randi Lynn Bodoh,
Richard K Glabach,
Roseline N Boateng,
Russ E Davis,
Samina S Khan,
Shannon A Dinardo,
Sherona A Ryder,
Sony Mathews,
State Agency,
Steven E Bowen, PhD,
Steven J Libal,
Tammy Notto,
Wendy M Stone,
William C Lubas,
William J Leonard,
William P Chilton,
Xiaokuang Lai, PhD
Tammy S Notto's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2000 | EIR | SpecGx LLC - EIR, 2000-01-12 |
January, 2000 | FDA 483 | American National Red Cross (the) - Form 483, 2000-01-25 |
April, 2000 | FDA 483 | Carestream Health, Inc. - Form 483, 2000-04-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more